EPL Ltd Q2 FY26 Earnings Analysis

- EPL Limited aims for sustained double-digit revenue growth, as indicated over multiple quarters. - Strong momentum in Beauty & Cosmetics is a key driver, with substantial headroom for further expansion. - Americas region expected to continue delivering higher-than-global-average double-digit growth, supported by broad-based country contributions. - Emerging markets like Thailand, with its new plant operational from Q3, present new growth opportunities and potential capacity expansions underway. - Oral Care volumes are expected to recover, complementing the strong growth from Beauty & Cosmetics. - Investments in sales capabilities, particularly in Beauty & Cosmetics, suggest plans for expanding market reach and innovation-led growth. - Overall growth will be a blend of organic expansion, geographical diversification, and capital-efficient operations. - The company also remains optimistic about growth recovery in regions like Europe, which faced temporary challenges.

- EPL Limited expects **sustained double-digit revenue growth** driven by geographical expansion and organic growth in existing countries. - Growth in the **Beauty & Cosmetics** segment is a key engine, showing strong momentum and significant headroom for further expansion. - Thailand plant startup is seen as a new growth driver with low overhead costs and quick breakeven potential. - The company aims for **gradual improvement in EBITDA margins** and expects EBITDA to grow faster than revenue. - Margins in Europe, currently under pressure due to de-stocking by a major customer, are expected to recover to mid-teens levels. - Effective tax rate guidance remains stable at around **20-22%**. - Earnings per share (EPS) showed improvement last quarter (INR 3.26 vs. INR 2.73), reflecting operational efficiency and profitable growth. - Overall, management is optimistic about **profitable double-digit growth** in earnings and returns.

- Thailand plant: Recently commissioned, built in just 9 months, currently operating with low overhead and limited indirect manning costs; plans for quick expansion with a modular setup to a second production line based on order pipeline. - Brazil plant: Already undergone one phase of expansion with production started from new line 3-4 months ago; no immediate new capex planned but proactive future investment based on volume growth expected. - Focus on capital efficiency and margin expansion initiatives continuing to improve ROCE, targeting 25%+ by FY '29. - No specific country-wise capex numbers disclosed due to complexity; overall capacity utilization between 60%-70%, with modular capacity additions to maintain optimal utilization. - Continuous investment in ramping up sales capability, especially in Beauty & Cosmetics, considered “good cost” that drives higher revenue and margins. - Strategic sourcing and partnerships being explored to mitigate US tariff impacts.

The transcript does not explicitly mention any current or planned new fundraising through debt or equity. However, some relevant points include: - EPL Limited is making modest capex investments, such as in the Thailand plant and Brazil capacity expansion. - The Thailand plant is set up with a creative model resulting in limited capex. - Expansion and capacity additions are planned to be modular and based on demand. - No specific comments on raising new funds via debt or equity in the near term. - The company emphasizes double-digit revenue growth and efficient cost management, implying organic funding of growth. - Anand Kripalu mentioned continuing investments but did not indicate any capital raise activities. Overall, no direct indication of fundraising plans through debt or equity in the provided discussion.

- The transcript does not explicitly mention the current or expected order book or pending orders for EPL Limited. - However, it indicates a strong business development pipeline, especially highlighted for the Thailand plant, with plans to expand capacity as orders build. - The management expresses confidence in growth opportunities, particularly in Beauty & Cosmetics and regions like Brazil and EAP, implying a robust and growing order pipeline. - No specific order book values or pending order quantities are disclosed in the provided transcript.